DHT.U Stock Overview
Focuses on managing and growing a portfolio of pharmaceutical royalties. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
DRI Healthcare Trust Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$8.25 |
| 52 Week High | CA$12.81 |
| 52 Week Low | CA$7.99 |
| Beta | 0.55 |
| 1 Month Change | -0.12% |
| 3 Month Change | -18.72% |
| 1 Year Change | -19.43% |
| 3 Year Change | 71.88% |
| 5 Year Change | n/a |
| Change since IPO | -15.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| DHT.U | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -4.1% | -2.5% | -0.4% |
| 1Y | -19.4% | -52.2% | 17.6% |
Return vs Industry: DHT.U exceeded the Canadian Pharmaceuticals industry which returned -52.2% over the past year.
Return vs Market: DHT.U underperformed the Canadian Market which returned 17.6% over the past year.
Price Volatility
| DHT.U volatility | |
|---|---|
| DHT.U Average Weekly Movement | 5.9% |
| Pharmaceuticals Industry Average Movement | 12.8% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: DHT.U has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: DHT.U's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | n/a | Behzad Khosrowshahi | www.dricapital.com |
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.
DRI Healthcare Trust Fundamentals Summary
| DHT.U fundamental statistics | |
|---|---|
| Market cap | US$455.10m |
| Earnings (TTM) | US$11.56m |
| Revenue (TTM) | US$201.07m |
39.4x
P/E Ratio2.3x
P/S RatioIs DHT.U overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DHT.U income statement (TTM) | |
|---|---|
| Revenue | US$201.07m |
| Cost of Revenue | US$0 |
| Gross Profit | US$201.07m |
| Other Expenses | US$189.51m |
| Earnings | US$11.56m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 03, 2025
| Earnings per share (EPS) | 0.21 |
| Gross Margin | 100.00% |
| Net Profit Margin | 5.75% |
| Debt/Equity Ratio | 65.1% |
How did DHT.U perform over the long term?
See historical performance and comparisonDividends
4.2%
Current Dividend Yield161%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/02 22:59 |
| End of Day Share Price | 2025/01/28 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
DRI Healthcare Trust is covered by 14 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Martin | Bloom Burton & Co. |
| Tania Armstrong-Whitworth | Canaccord Genuity |
| Scott Fletcher | CIBC Capital Markets |